F M Investments LLC Sells 42,777 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

F M Investments LLC decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 61.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,624 shares of the medical instruments supplier's stock after selling 42,777 shares during the period. F M Investments LLC owned about 0.11% of ICU Medical worth $4,131,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Barclays PLC lifted its stake in ICU Medical by 15.6% during the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock valued at $10,790,000 after acquiring an additional 8,010 shares during the period. Principal Financial Group Inc. grew its position in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after purchasing an additional 25,031 shares during the period. Vanguard Group Inc. lifted its holdings in shares of ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock valued at $416,176,000 after buying an additional 17,805 shares during the period. Jennison Associates LLC purchased a new position in shares of ICU Medical in the 4th quarter worth $556,000. Finally, Geode Capital Management LLC grew its holdings in shares of ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after acquiring an additional 48,106 shares during the period. 96.10% of the stock is owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several brokerages have issued reports on ICUI. Raymond James set a $97.00 target price on ICU Medical in a research report on Wednesday, March 12th. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday, April 4th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, ICU Medical presently has a consensus rating of "Buy" and an average target price of $168.67.

ICU Medical Stock Performance

ICU Medical stock traded down $0.90 during midday trading on Tuesday, hitting $139.64. The stock had a trading volume of 148,529 shares, compared to its average volume of 269,047. ICU Medical, Inc. has a 52-week low of $93.36 and a 52-week high of $196.26. The company has a market capitalization of $3.42 billion, a PE ratio of -30.56 and a beta of 0.86. The firm's fifty day moving average is $147.87 and its two-hundred day moving average is $160.62. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.